Ertumaxomab: Difference between revisions

Jump to navigation Jump to search
m (Protected "Ertumaxomab": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
m (Bot: Automated text replacement (-{{SIB}} + & -{{EJ}} + & -{{EH}} + & -{{Editor Join}} + & -{{Editor Help}} +))
 
Line 26: Line 26:
}}
}}
{{SI}}
{{SI}}
{{EH}}
 


==Overview==
==Overview==
Line 33: Line 33:


{{rat-murinehybridmonoclonals}}
{{rat-murinehybridmonoclonals}}
{{SIB}}
 
[[Category:Monoclonal antibodies]]
[[Category:Monoclonal antibodies]]
[[Category:Cancer treatments]]
[[Category:Cancer treatments]]
{{WH}}
{{WH}}
{{WS}}
{{WS}}

Latest revision as of 02:22, 9 August 2012

Template:Drugbox-mab

WikiDoc Resources for Ertumaxomab

Articles

Most recent articles on Ertumaxomab

Most cited articles on Ertumaxomab

Review articles on Ertumaxomab

Articles on Ertumaxomab in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Ertumaxomab

Images of Ertumaxomab

Photos of Ertumaxomab

Podcasts & MP3s on Ertumaxomab

Videos on Ertumaxomab

Evidence Based Medicine

Cochrane Collaboration on Ertumaxomab

Bandolier on Ertumaxomab

TRIP on Ertumaxomab

Clinical Trials

Ongoing Trials on Ertumaxomab at Clinical Trials.gov

Trial results on Ertumaxomab

Clinical Trials on Ertumaxomab at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Ertumaxomab

NICE Guidance on Ertumaxomab

NHS PRODIGY Guidance

FDA on Ertumaxomab

CDC on Ertumaxomab

Books

Books on Ertumaxomab

News

Ertumaxomab in the news

Be alerted to news on Ertumaxomab

News trends on Ertumaxomab

Commentary

Blogs on Ertumaxomab

Definitions

Definitions of Ertumaxomab

Patient Resources / Community

Patient resources on Ertumaxomab

Discussion groups on Ertumaxomab

Patient Handouts on Ertumaxomab

Directions to Hospitals Treating Ertumaxomab

Risk calculators and risk factors for Ertumaxomab

Healthcare Provider Resources

Symptoms of Ertumaxomab

Causes & Risk Factors for Ertumaxomab

Diagnostic studies for Ertumaxomab

Treatment of Ertumaxomab

Continuing Medical Education (CME)

CME Programs on Ertumaxomab

International

Ertumaxomab en Espanol

Ertumaxomab en Francais

Business

Ertumaxomab in the Marketplace

Patents on Ertumaxomab

Experimental / Informatics

List of terms related to Ertumaxomab


Overview

Ertumaxomab (marketed under the brand name Rexomun®) is a rat-murine hybrid monoclonal antibody which it's used to treat some cancers.


Template:Rat-murinehybridmonoclonals Template:WH Template:WS